— The Clorox Company (NYSE: CLX) reported net income of $185 million or $1.46 per share for the second quarter of 2020, vs. $1.40 per share expected.
— Net sales decreased to $1.45 billion from $1.47 billion in the second quarter of 2019, vs. $1.43 billion expected; organic sales were flat
— Gross margin rose 40 basis points to 44.1% from 43.7% in the year-ago quarter
— Expects the year-over-year change in full-year 2020 net sales to be between a low-single-digit decline to a 1% increase; sees organic sales growth of 2%
— Expects full-year earnings per share to be between $6.10 and $6.25, representing a 3-1% annual decrease
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
